Remember Dr. Infante, the scientist who was set to serve on the Environmental Protection Agency panel on the carcinogenicity of glyphosate until the agrichemical industry objected?

To refresh your memory, Dr. Infante was removed from the EPA panel after CropLife America, a trade group for Monsanto and other agribusinesses, took issue with Dr. Infante and another scientist set to be on the panel, complaining that they were biased against the industry. 

The EPA unfortunately caved to the industry by postponing the hearings and removing Dr. Infante from the panel, despite the fact that he is an expert in his field with years of experience, including work for the Occupational Safety and Health Administration and the World Trade Organization.

The hearings finally happened this week, and Dr. Infante did attend them, but not as a part of the final EPA panel. After studying data that the EPA had sent panel members in advance, Dr. Infante told the panel members that there is evidence of glyphosate's ties to cancer.

In an interview after he addressed the panel, Dr. Infante made his voice heard.

There is clearly evidence for the risk of non-Hodgkin lymphoma related to glyphosate expsoure. Is it conclusive? No, I don’t think so. But I think that EPA is concluding that there is no evidence. And that’s exactly wrong, according to their own criteria. There is enough data to classify glyphosate as having ‘limited’ evidence of carcinogenicity in humans.
— Dr. Peter Infante
Dr. Infante is pictured here at the hearings. Photo credit: Carey Gillam, U.S. Right to Know

Dr. Infante is pictured here at the hearings. Photo credit: Carey Gillam, U.S. Right to Know